Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Nov 15, 2013 and accepted by EDGAR at Nov 14, 2013, 23:10 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Gross profit3 months2013-07-01 to 2013-09-30$252us-gaap:GrossProfit
Gross profit9 months2013-01-01 to 2013-09-30$1.1kus-gaap:GrossProfit
Interest expense3 months2013-07-01 to 2013-09-30−$401us-gaap:InterestExpense
Interest expense9 months2013-01-01 to 2013-09-30−$1.1kus-gaap:InterestExpense
Net income3 months2013-07-01 to 2013-09-30−$5.1kus-gaap:NetIncomeLoss
Net income9 months2013-01-01 to 2013-09-30−$27.6kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-07-01 to 2013-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2013-01-01 to 2013-09-30−$22.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2013-09-30$608us-gaap:Cash
Current assetsAt period end2013-09-30$608us-gaap:AssetsCurrent
Total assetsAt period end2013-09-30$608us-gaap:Assets
Current liabilitiesAt period end2013-09-30$28.9kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-09-30$28.9kus-gaap:Liabilities
Shareholders' equityAt period end2013-09-30−$28.3kus-gaap:StockholdersEquity
Shares outstandingAt period end2013-09-306,573,000 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001014897-13-000417. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.